Activated AMPK will inhibit human cancer cells via regulating its downstream effectors, causing mTORC1 inhibition23,24,42, autophagy induction42–44, and receptor tyrosine kinase (RTK) degradation10,26. Here, PRKAA1 is linked to cancer.